Integrating background subtraction and metabolomics technology to study the difference of serum chemical profile before and after compatibility of Radix Bupleuri and Radix Paeoniae Alba
Background: Radix Bupleuri-Radix Paeoniae Alba (CH-BS) is a common clinical herb pair, which is often used to treat depression. However, there is little known about the difference in serum chemical profile before and after the compatibility of Radix Bupleuri (CH) and Radix Paeoniae Alba (BS). Object...
Gespeichert in:
Veröffentlicht in: | Pharmacognosy Magazine 2022-10, Vol.18 (80), p.1160-1169 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1169 |
---|---|
container_issue | 80 |
container_start_page | 1160 |
container_title | Pharmacognosy Magazine |
container_volume | 18 |
creator | Chen, Congcong Hou, Ruihong Yin, Qicai Tian, Junshen Gao, Xiaoxia Qin, Xuemei Du, Guanhua Zhou, Yuzhi |
description | Background: Radix Bupleuri-Radix Paeoniae Alba (CH-BS) is a common clinical herb pair, which is often used to treat depression. However, there is little known about the difference in serum chemical profile before and after the compatibility of Radix Bupleuri (CH) and Radix Paeoniae Alba (BS). Objectives: Here, an effective strategy has been developed for screening differences of constituents in vivo before and after compatibility by integrating background subtraction and metabolomics technology. Materials and Methods: First, to obtain the chemical composition from the CH in vivo before compatibility, the Liquid chromatography/Mass spectrometry (LC/MS) data of serum samples in the control group were subtracted from serum samples in the CH group based on the background subtraction method. Moreover, the chemical composition from the CH in vivo after compatibility was obtained by subtracting the LC/MS data of serum samples in the BS group from serum samples in the CH-BS compatibility group. Finally, the difference in the chemical composition from the CH in vivo before and after compatibility was screened and analyzed by metabolomics. Meanwhile, the difference in chemical composition from the BS in vivo before and after the compatibility was found according to the same thought with BS. Results: The results showed that three prototype components were significantly decreased and seven metabolites were significantly increased in CH after compatibility. And eight prototype components and six metabolites were significantly increased in BS after compatibility. Conclusion: An effective strategy has been developed for screening differences of constituents in vivo before and after compatibility by combining background subtraction and metabolomics. |
doi_str_mv | 10.4103/pm.pm_139_22 |
format | Article |
fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_journals_2745731515</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A728924348</galeid><sourcerecordid>A728924348</sourcerecordid><originalsourceid>FETCH-LOGICAL-g236t-f041fe920555ed8dcb48f661c999e7a39462456e4d5f963f119c8824d9bff4813</originalsourceid><addsrcrecordid>eNptUV2L1DAULaLguvrmDwj4PGOSpmnzJOOi7sKCIvoc0uSmk500qWnK7P40_53pzKoIch_uB-fcyz2nql4TvGUE12-ncTuNktRCUvqkusCi5RuGOX16qusNoYI_r17M8x3GTUdwe1H9vAkZhqSyCwPqlT4MKS7BoHnpc1I6uxiQKv0IWfXRx9HpGWXQ-1Ca4QHliOa8mFLsARlnLSQIGlC0aIa0jEjvoXCUR1OK1nlAPdiY4LRU2QwJ6ThO5X7vvMsPK_GrMu4evV8mD0tyJ-R59EVBDE4B2vlevayeWeVnePWYL6vvHz98u7re3H7-dHO1u90MtOZ5YzEjFgTFTdOA6YzuWWc5J1oIAa2qBeOUNRyYaazgtSVE6K6jzIjeWtaR-rJ6c95bHvixwJzlXVxSKCclbVnT1qQhzV_UoDxIF2xc5RvdrOWupZ2grGZdQW3_gyphVpFigFWhfwnvzoRj9EWr-eCXIyQ5gjmEeJQEy9V4WVz_Y7wkhGP529b6F9fjqhI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2745731515</pqid></control><display><type>article</type><title>Integrating background subtraction and metabolomics technology to study the difference of serum chemical profile before and after compatibility of Radix Bupleuri and Radix Paeoniae Alba</title><source>EZB Electronic Journals Library</source><creator>Chen, Congcong ; Hou, Ruihong ; Yin, Qicai ; Tian, Junshen ; Gao, Xiaoxia ; Qin, Xuemei ; Du, Guanhua ; Zhou, Yuzhi</creator><creatorcontrib>Chen, Congcong ; Hou, Ruihong ; Yin, Qicai ; Tian, Junshen ; Gao, Xiaoxia ; Qin, Xuemei ; Du, Guanhua ; Zhou, Yuzhi</creatorcontrib><description>Background: Radix Bupleuri-Radix Paeoniae Alba (CH-BS) is a common clinical herb pair, which is often used to treat depression. However, there is little known about the difference in serum chemical profile before and after the compatibility of Radix Bupleuri (CH) and Radix Paeoniae Alba (BS). Objectives: Here, an effective strategy has been developed for screening differences of constituents in vivo before and after compatibility by integrating background subtraction and metabolomics technology. Materials and Methods: First, to obtain the chemical composition from the CH in vivo before compatibility, the Liquid chromatography/Mass spectrometry (LC/MS) data of serum samples in the control group were subtracted from serum samples in the CH group based on the background subtraction method. Moreover, the chemical composition from the CH in vivo after compatibility was obtained by subtracting the LC/MS data of serum samples in the BS group from serum samples in the CH-BS compatibility group. Finally, the difference in the chemical composition from the CH in vivo before and after compatibility was screened and analyzed by metabolomics. Meanwhile, the difference in chemical composition from the BS in vivo before and after the compatibility was found according to the same thought with BS. Results: The results showed that three prototype components were significantly decreased and seven metabolites were significantly increased in CH after compatibility. And eight prototype components and six metabolites were significantly increased in BS after compatibility. Conclusion: An effective strategy has been developed for screening differences of constituents in vivo before and after compatibility by combining background subtraction and metabolomics.</description><identifier>ISSN: 0973-1296</identifier><identifier>EISSN: 0976-4062</identifier><identifier>DOI: 10.4103/pm.pm_139_22</identifier><language>eng</language><publisher>London: Wolters Kluwer India Pvt. Ltd</publisher><subject>Depression, Mental ; Metabolites</subject><ispartof>Pharmacognosy Magazine, 2022-10, Vol.18 (80), p.1160-1169</ispartof><rights>COPYRIGHT 2022 Medknow Publications and Media Pvt. Ltd.</rights><rights>2022. This article is published under (http://creativecommons.org/licenses/by-nc-sa/3.0/) (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids></links><search><creatorcontrib>Chen, Congcong</creatorcontrib><creatorcontrib>Hou, Ruihong</creatorcontrib><creatorcontrib>Yin, Qicai</creatorcontrib><creatorcontrib>Tian, Junshen</creatorcontrib><creatorcontrib>Gao, Xiaoxia</creatorcontrib><creatorcontrib>Qin, Xuemei</creatorcontrib><creatorcontrib>Du, Guanhua</creatorcontrib><creatorcontrib>Zhou, Yuzhi</creatorcontrib><title>Integrating background subtraction and metabolomics technology to study the difference of serum chemical profile before and after compatibility of Radix Bupleuri and Radix Paeoniae Alba</title><title>Pharmacognosy Magazine</title><description>Background: Radix Bupleuri-Radix Paeoniae Alba (CH-BS) is a common clinical herb pair, which is often used to treat depression. However, there is little known about the difference in serum chemical profile before and after the compatibility of Radix Bupleuri (CH) and Radix Paeoniae Alba (BS). Objectives: Here, an effective strategy has been developed for screening differences of constituents in vivo before and after compatibility by integrating background subtraction and metabolomics technology. Materials and Methods: First, to obtain the chemical composition from the CH in vivo before compatibility, the Liquid chromatography/Mass spectrometry (LC/MS) data of serum samples in the control group were subtracted from serum samples in the CH group based on the background subtraction method. Moreover, the chemical composition from the CH in vivo after compatibility was obtained by subtracting the LC/MS data of serum samples in the BS group from serum samples in the CH-BS compatibility group. Finally, the difference in the chemical composition from the CH in vivo before and after compatibility was screened and analyzed by metabolomics. Meanwhile, the difference in chemical composition from the BS in vivo before and after the compatibility was found according to the same thought with BS. Results: The results showed that three prototype components were significantly decreased and seven metabolites were significantly increased in CH after compatibility. And eight prototype components and six metabolites were significantly increased in BS after compatibility. Conclusion: An effective strategy has been developed for screening differences of constituents in vivo before and after compatibility by combining background subtraction and metabolomics.</description><subject>Depression, Mental</subject><subject>Metabolites</subject><issn>0973-1296</issn><issn>0976-4062</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNptUV2L1DAULaLguvrmDwj4PGOSpmnzJOOi7sKCIvoc0uSmk500qWnK7P40_53pzKoIch_uB-fcyz2nql4TvGUE12-ncTuNktRCUvqkusCi5RuGOX16qusNoYI_r17M8x3GTUdwe1H9vAkZhqSyCwPqlT4MKS7BoHnpc1I6uxiQKv0IWfXRx9HpGWXQ-1Ca4QHliOa8mFLsARlnLSQIGlC0aIa0jEjvoXCUR1OK1nlAPdiY4LRU2QwJ6ThO5X7vvMsPK_GrMu4evV8mD0tyJ-R59EVBDE4B2vlevayeWeVnePWYL6vvHz98u7re3H7-dHO1u90MtOZ5YzEjFgTFTdOA6YzuWWc5J1oIAa2qBeOUNRyYaazgtSVE6K6jzIjeWtaR-rJ6c95bHvixwJzlXVxSKCclbVnT1qQhzV_UoDxIF2xc5RvdrOWupZ2grGZdQW3_gyphVpFigFWhfwnvzoRj9EWr-eCXIyQ5gjmEeJQEy9V4WVz_Y7wkhGP529b6F9fjqhI</recordid><startdate>20221001</startdate><enddate>20221001</enddate><creator>Chen, Congcong</creator><creator>Hou, Ruihong</creator><creator>Yin, Qicai</creator><creator>Tian, Junshen</creator><creator>Gao, Xiaoxia</creator><creator>Qin, Xuemei</creator><creator>Du, Guanhua</creator><creator>Zhou, Yuzhi</creator><general>Wolters Kluwer India Pvt. Ltd</general><general>Medknow Publications and Media Pvt. Ltd</general><general>Sage Publications Ltd</general><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope></search><sort><creationdate>20221001</creationdate><title>Integrating background subtraction and metabolomics technology to study the difference of serum chemical profile before and after compatibility of Radix Bupleuri and Radix Paeoniae Alba</title><author>Chen, Congcong ; Hou, Ruihong ; Yin, Qicai ; Tian, Junshen ; Gao, Xiaoxia ; Qin, Xuemei ; Du, Guanhua ; Zhou, Yuzhi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g236t-f041fe920555ed8dcb48f661c999e7a39462456e4d5f963f119c8824d9bff4813</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Depression, Mental</topic><topic>Metabolites</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chen, Congcong</creatorcontrib><creatorcontrib>Hou, Ruihong</creatorcontrib><creatorcontrib>Yin, Qicai</creatorcontrib><creatorcontrib>Tian, Junshen</creatorcontrib><creatorcontrib>Gao, Xiaoxia</creatorcontrib><creatorcontrib>Qin, Xuemei</creatorcontrib><creatorcontrib>Du, Guanhua</creatorcontrib><creatorcontrib>Zhou, Yuzhi</creatorcontrib><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Databases</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><jtitle>Pharmacognosy Magazine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chen, Congcong</au><au>Hou, Ruihong</au><au>Yin, Qicai</au><au>Tian, Junshen</au><au>Gao, Xiaoxia</au><au>Qin, Xuemei</au><au>Du, Guanhua</au><au>Zhou, Yuzhi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Integrating background subtraction and metabolomics technology to study the difference of serum chemical profile before and after compatibility of Radix Bupleuri and Radix Paeoniae Alba</atitle><jtitle>Pharmacognosy Magazine</jtitle><date>2022-10-01</date><risdate>2022</risdate><volume>18</volume><issue>80</issue><spage>1160</spage><epage>1169</epage><pages>1160-1169</pages><issn>0973-1296</issn><eissn>0976-4062</eissn><abstract>Background: Radix Bupleuri-Radix Paeoniae Alba (CH-BS) is a common clinical herb pair, which is often used to treat depression. However, there is little known about the difference in serum chemical profile before and after the compatibility of Radix Bupleuri (CH) and Radix Paeoniae Alba (BS). Objectives: Here, an effective strategy has been developed for screening differences of constituents in vivo before and after compatibility by integrating background subtraction and metabolomics technology. Materials and Methods: First, to obtain the chemical composition from the CH in vivo before compatibility, the Liquid chromatography/Mass spectrometry (LC/MS) data of serum samples in the control group were subtracted from serum samples in the CH group based on the background subtraction method. Moreover, the chemical composition from the CH in vivo after compatibility was obtained by subtracting the LC/MS data of serum samples in the BS group from serum samples in the CH-BS compatibility group. Finally, the difference in the chemical composition from the CH in vivo before and after compatibility was screened and analyzed by metabolomics. Meanwhile, the difference in chemical composition from the BS in vivo before and after the compatibility was found according to the same thought with BS. Results: The results showed that three prototype components were significantly decreased and seven metabolites were significantly increased in CH after compatibility. And eight prototype components and six metabolites were significantly increased in BS after compatibility. Conclusion: An effective strategy has been developed for screening differences of constituents in vivo before and after compatibility by combining background subtraction and metabolomics.</abstract><cop>London</cop><pub>Wolters Kluwer India Pvt. Ltd</pub><doi>10.4103/pm.pm_139_22</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0973-1296 |
ispartof | Pharmacognosy Magazine, 2022-10, Vol.18 (80), p.1160-1169 |
issn | 0973-1296 0976-4062 |
language | eng |
recordid | cdi_proquest_journals_2745731515 |
source | EZB Electronic Journals Library |
subjects | Depression, Mental Metabolites |
title | Integrating background subtraction and metabolomics technology to study the difference of serum chemical profile before and after compatibility of Radix Bupleuri and Radix Paeoniae Alba |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T19%3A50%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Integrating%20background%20subtraction%20and%20metabolomics%20technology%20to%20study%20the%20difference%20of%20serum%20chemical%20profile%20before%20and%20after%20compatibility%20of%20Radix%20Bupleuri%20and%20Radix%20Paeoniae%20Alba&rft.jtitle=Pharmacognosy%20Magazine&rft.au=Chen,%20Congcong&rft.date=2022-10-01&rft.volume=18&rft.issue=80&rft.spage=1160&rft.epage=1169&rft.pages=1160-1169&rft.issn=0973-1296&rft.eissn=0976-4062&rft_id=info:doi/10.4103/pm.pm_139_22&rft_dat=%3Cgale_proqu%3EA728924348%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2745731515&rft_id=info:pmid/&rft_galeid=A728924348&rfr_iscdi=true |